Page last updated: 2024-10-25

deferoxamine and Osteolysis

deferoxamine has been researched along with Osteolysis in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Osteolysis: Dissolution of bone that particularly involves the removal or loss of calcium.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kang, H1
Yan, Y1
Jia, P1
Yang, K1
Guo, C1
Chen, H1
Qi, J1
Qian, N1
Xu, X1
Wang, F1
Li, C1
Guo, L1
Deng, L1

Other Studies

1 other study available for deferoxamine and Osteolysis

ArticleYear
Desferrioxamine reduces ultrahigh-molecular-weight polyethylene-induced osteolysis by restraining inflammatory osteoclastogenesis via heme oxygenase-1.
    Cell death & disease, 2016, 10-27, Volume: 7, Issue:10

    Topics: Actins; Animals; Bone Resorption; Deferoxamine; Gene Expression Regulation; Heme Oxygenase-1; Inflam

2016